{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:05:21Z","timestamp":1792317921910,"version":"4.4.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RG-1441-534"],"award-info":[{"award-number":["RG-1441-534"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013302","name":"King Abdullah International Medical Research Center","doi-asserted-by":"publisher","award":["RC20\/153\/R"],"award-info":[{"award-number":["RC20\/153\/R"]}],"id":[{"id":"10.13039\/501100013302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cjco.2021.04.004","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T11:03:53Z","timestamp":1618571033000},"page":"1060-1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Classical and Counter-Regulatory Renin\u2013Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7226-7095","authenticated-orcid":false,"given":"Moudhi","family":"Almutlaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir Abdullah","family":"Alamro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayhan","family":"Alroqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tlili","family":"Barhoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2021.04.004_bib0001","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrcardio.2016.127","article-title":"Immune system and cardiovascular disease","volume":"13","author":"Fern\u00e1ndez-Ruiz","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.110.162941","article-title":"T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury","volume":"57","author":"Barhoumi","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.04.004_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009372","article-title":"CD4(+) regulatory T lymphocytes prevent impaired cerebral blood flow in angiotensin ii-induced hypertension","volume":"8","author":"Iulita","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjco.2021.04.004_bib0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/HYPERTENSIONAHA.113.01298","article-title":"Reduced macrophage-dependent inflammation improves endothelin-1-induced vascular injury","volume":"62","author":"Javeshghani","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.04.004_bib0005","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.1161\/ATVBAHA.118.311282","article-title":"Renin-angiotensin system and cardiovascular functions","volume":"38","author":"Wu","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0006","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jgs.16472","article-title":"COVID-19 and older adults: what we know","volume":"68","author":"Shahid","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.cjco.2021.04.004_bib0007","doi-asserted-by":"crossref","first-page":"280","DOI":"10.21037\/atm-20-4052","article-title":"The clinical characteristics and prognosis of COVID-19 patients with comorbidities: a retrospective analysis of the infection peak in Wuhan","volume":"9","author":"Dong","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.57278","article-title":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients","volume":"9","author":"Rossi","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.cjco.2021.04.004_bib0009","doi-asserted-by":"crossref","first-page":"e2113","DOI":"10.1002\/rmv.2113","article-title":"Three months of COVID-19: a systematic review and meta-analysis","volume":"30","author":"Rafiq","year":"2020","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0010","unstructured":"World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available at: https:\/\/covid19.who.int\/. Accessed June 14, 2020."},{"key":"10.1016\/j.cjco.2021.04.004_bib0011","first-page":"1","article-title":"COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection","author":"Beyerstedt","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cjco.2021.04.004_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13054-018-2202-y","article-title":"Angiotensin converting enzyme defects in shock: Implications for future therapy","volume":"22","author":"Chawla","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.cjco.2021.04.004_bib0013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0014","first-page":"L885","article-title":"Angiotensin II induces apoptosis in human and rat alveolar epithelial cells","volume":"276","author":"Wang","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jss.2007.03.075","article-title":"Losartan attenuates ventilator-induced lung injury","volume":"145","author":"Yao","year":"2008","journal-title":"J Surg Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0016","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11033-013-2920-9","article-title":"Losartan attenuates microvascular permeability in mechanical ventilator-induced lung injury in diabetic mice","volume":"41","author":"Chen","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.cjco.2021.04.004_bib0017","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00134-009-1545-x","article-title":"Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats","volume":"35","author":"Hagiwara","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0018","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/138161212799436593","article-title":"Role of renin-angiotensin system in inflammation, immunity and aging","volume":"18","author":"Capettini","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cjco.2021.04.004_bib0019","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1161\/CIRCULATIONAHA.116.027058","article-title":"\u03b3\u03b4 T cells mediate angiotensin II-induced hypertension and vascular injury","volume":"135","author":"Caillon","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.04.004_bib0020","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjco.2021.04.004_bib0021","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(94)91171-1","article-title":"Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors","volume":"665","author":"Fontes","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0022","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11906-010-0105-7","article-title":"Angiotensin-converting enzyme 2: central regulator for cardiovascular function","volume":"12","author":"Xia","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.cjco.2021.04.004_bib0023","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/01.HYP.29.1.394","article-title":"Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide","volume":"29","author":"Li","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.04.004_bib0024","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.metabol.2019.03.006","article-title":"Angiotensin-(1-7), adipokines and inflammation","volume":"95","author":"Lelis","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.cjco.2021.04.004_bib0025","doi-asserted-by":"crossref","first-page":"L341","DOI":"10.1152\/ajplung.00360.2012","article-title":"Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury","volume":"305","author":"Wagenaar","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0026","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin\u2013angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0027","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00726-018-2583-x","article-title":"Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats","volume":"50","author":"Liu","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.cjco.2021.04.004_bib0028","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1253\/circj.CJ-17-1381","article-title":"Alamandine protects the heart against reperfusion injury via the MrgD receptor","volume":"82","author":"Park","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.cjco.2021.04.004_bib0029","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/HJH.0000000000000094","article-title":"Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme\/Ang II axis","volume":"32","author":"Ocaranza","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjco.2021.04.004_bib0030","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/HJH.0b013e328335d291","article-title":"Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro","volume":"28","author":"Ocaranza","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjco.2021.04.004_bib0031","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.phrs.2018.07.022","article-title":"Protection of the myocardium against ischemia\/reperfusion injury by angiotensin-(1\u20139) through an AT 2 R and Akt-dependent mechanism","volume":"135","author":"Mendoza-Torres","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0032","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4196\/kjpp.2018.22.4.447","article-title":"Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor","volume":"22","author":"Cha","year":"2018","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0033","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bcp.2018.08.045","article-title":"Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension","volume":"156","author":"Gonzalez","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0034","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/CS20130449","article-title":"Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system","volume":"127","author":"Ocaranza","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cjco.2021.04.004_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/594361","article-title":"Protective role of the ACE2\/Ang-(19) axis in cardiovascular remodeling","volume":"2012","author":"Ocaranza","year":"2012","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.cjco.2021.04.004_bib0036","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/bph.13044","article-title":"Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis","volume":"172","author":"Bruce","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.00180","article-title":"The selective angiotensin II type 2 receptor agonist, compound 21, attenuates the progression of lung fibrosis and pulmonary hypertension in an experimental model of bleomycin-induced lung injury","volume":"9","author":"Rathinasabapathy","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0038","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/JIR.S160573","article-title":"Angiotensin II type 2 receptor agonist compound 21 attenuates pulmonary inflammation in a model of acute lung injury","volume":"11","author":"Menk","year":"2018","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0039","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.04.004_bib0040","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/0929867324666170414162841","article-title":"Circulating ACE2 in cardiovascular and kidney diseases","volume":"24","author":"Anguiano","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cjco.2021.04.004_bib0041","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International Union of Pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.cjco.2021.04.004_bib0042","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.184911","article-title":"Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart","volume":"103","author":"Mercure","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0043","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","article-title":"ACE2, angiotensin-(1-7), and Mas: the other side of the coin","volume":"465","author":"Bader","year":"2013","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0044","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1113\/expphysiol.2007.040345","article-title":"Genetically altered animal models for Mas and angiotensin-(1-7)","volume":"93","author":"Alenina","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0045","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cjco.2021.04.004_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0047","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/qjmed\/hcz206","article-title":"Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-jB and Nrf2 pathways","volume":"112","author":"Fang","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.cjco.2021.04.004_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0224163","article-title":"Ang-(1-7)\/MAS1 receptor axis inhibits allergic airway inflammation via blockade of Src-mediated EGFR transactivation in a murine model of asthma","volume":"14","author":"El-Hashim","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cjco.2021.04.004_bib0049","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","author":"Gheblawi","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0050","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1042\/CS20200492","article-title":"Covid-19: the renin-angiotensin system imbalance hypothesis","volume":"134","author":"Lanza","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cjco.2021.04.004_bib0051","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.15420\/cfr.2020.10","article-title":"Mechanisms of myocardial injury in coronavirus disease 2019","volume":"6","author":"Rali","year":"2020","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.cjco.2021.04.004_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2019.101833","article-title":"Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation","volume":"58","author":"Wang","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.cjco.2021.04.004_bib0053","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cjco.2021.04.004_bib0054","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cjco.2021.04.004_bib0055","volume":"9","author":"Guo","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjco.2021.04.004_bib0056","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1\u20137 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0057","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.118.017129","article-title":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure","volume":"71","author":"Arendse","year":"2019","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.cjco.2021.04.004_bib0058","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1152\/ajpcell.00346.2012","article-title":"Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry","volume":"304","author":"Grobe","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0059","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-0115(98)00134-7","article-title":"Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system","volume":"78","author":"Ferrario","year":"1998","journal-title":"Regul Pept"},{"key":"10.1016\/j.cjco.2021.04.004_bib0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1055\/s-0040-1712960","article-title":"Impaired breakdown of bradykinin and its metabolites as a possible cause for pulmonary edema in COVID-19 infection","volume":"46","author":"de Maat","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cjco.2021.04.004_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-021-05027-9","article-title":"Evaluation of the efficacy and safety of icatibant and C1 esterase\/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial","volume":"22","author":"Mansour","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.cjco.2021.04.004_bib0062","doi-asserted-by":"crossref","first-page":"H1978","DOI":"10.1152\/ajpheart.01116.2002","article-title":"Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems\u2013endopeptidases 3.4. 24.15 and 24.16 in endothelial cells: potential role in vasoactive peptide metabolism","volume":"284","author":"Norman","year":"2003","journal-title":"Am J Physiol Hear Circ Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0063","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1016\/S0021-9258(17)34557-X","article-title":"Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney","volume":"253","author":"Odya","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjco.2021.04.004_bib0064","first-page":"589","article-title":"T\u03b24\u2013Ac-SDKP pathway: any relevance for the cardiovascular system?","volume":"97","author":"Kassem","year":"2019","journal-title":"Physiol Behav"},{"key":"10.1016\/j.cjco.2021.04.004_bib0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0066","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2021.04.004_bib0067","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0068","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2021.04.004_bib0069","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2021.04.004_bib0070","unstructured":"Ikram OO, Melenotte C, Brouqui P, et al. Expression of ACE2 receptor soluble ACE2 angiotensin I angiotensin II and angiotensin (1-7) is modulated in COVID-19 patients. Available at: https:\/\/medrxiv.org\/cgi\/content\/short\/2021.02.08.21251001."},{"key":"10.1016\/j.cjco.2021.04.004_bib0071","first-page":"F62","article-title":"Inhibition of renin release from rat kidney slices by the angiotensin","volume":"235","author":"Naftilan","year":"1978","journal-title":"Am J Physiol"},{"issue":"8 suppl B","key":"10.1016\/j.cjco.2021.04.004_bib0072","first-page":"9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","author":"Atlas","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.cjco.2021.04.004_bib0073","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ijcard.2012.10.007","article-title":"The past, present and future of renin\u2013angiotensin aldosterone system inhibition","volume":"167","author":"Mentz","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0074","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.HYP.38.3.665","article-title":"Angiotensin-(1-7): cardioprotective effect in myocardial ischemia\/reperfusion","volume":"38","author":"Ferreira","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.04.004_bib0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3317\/jraas.2004.041","article-title":"Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump","volume":"5","author":"De Mello","year":"2004","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"10.1016\/j.cjco.2021.04.004_bib0076","doi-asserted-by":"crossref","first-page":"C702","DOI":"10.1152\/ajpcell.00153.2017","article-title":"Alamandine acts via MrgD to induce AMPK\/NO activation against ANG II hypertrophy in cardiomyocytes","volume":"314","author":"Guedes de Jesus","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0077","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/CS20180547","article-title":"Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice","volume":"133","author":"de Souza-Neto","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cjco.2021.04.004_bib0078","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/jce.14479","article-title":"Cardiac and arrhythmic complications in patients with COVID-19","volume":"31","author":"Kochi","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0079","first-page":"1068","article-title":"Cardiovascular implications of the COVID-19 pandemic: a global perspective","volume":"36","author":"Boukhris","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0080","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0081","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacbts.2021.01.002","article-title":"SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis","volume":"6","author":"Bailey","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cjco.2021.04.004_bib0082","doi-asserted-by":"crossref","first-page":"e13859","DOI":"10.1111\/dth.13859","article-title":"Unraveling the mystery of Covid-19 cytokine storm: from skin to organ systems","volume":"33","author":"Garg","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.cjco.2021.04.004_bib0083","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00134-020-06120-4","article-title":"Clinical phenotypes of critically ill COVID-19 patients","volume":"46","author":"Azoulay","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0084","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/gerona\/glaa146","article-title":"Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy","volume":"75","author":"Palmieri","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.cjco.2021.04.004_bib0085","first-page":"e8426","article-title":"A review of acute myocardial injury in coronavirus disease 2019","volume":"12","author":"Anupama","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.cjco.2021.04.004_bib0086","first-page":"295","article-title":"Advantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases","volume":"64","author":"Gerc","year":"2010","journal-title":"Med Arh"},{"key":"10.1016\/j.cjco.2021.04.004_bib0087","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/ndt\/gfn736","article-title":"Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells","volume":"24","author":"Gava","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjco.2021.04.004_bib0088","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/cells9071583","article-title":"Vasculopathy and coagulopathy associated with SARS-CoV-2 infection","volume":"9","author":"Lab\u00f2","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cjco.2021.04.004_bib0089","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1183\/13993003.01028-2020","article-title":"Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers","volume":"55","author":"Rello","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjco.2021.04.004_bib0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2020.06.010","article-title":"Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?","volume":"193","author":"van Dam","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2020.103455","article-title":"Distinct phenotypes require distinct respiratory management strategies in severe COVID-19","volume":"279","author":"Robba","year":"2020","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0092","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0093","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/jcm9051417","article-title":"Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence","volume":"9","author":"Sardu","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0094","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3317\/jraas.2000.041","article-title":"The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan","volume":"1","author":"Kucharewicz","year":"2000","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"10.1016\/j.cjco.2021.04.004_bib0095","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.0000035396.27909.40","article-title":"Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7)","volume":"40","author":"Kucharewicz","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.04.004_bib0096","first-page":"e3377","article-title":"Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (COVID-19)","author":"Zhou","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.cjco.2021.04.004_bib0097","doi-asserted-by":"crossref","first-page":"bqaa112","DOI":"10.1210\/endocr\/bqaa112","article-title":"Metabolic syndrome and COVID 19: endocrine-immune-vascular interactions shapes clinical course","volume":"161","author":"Bansal","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.cjco.2021.04.004_bib0098","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4093\/dmj.2020.0146","article-title":"The clinical characteristics and outcomes of patients with moderate-to-severe coronavirus disease 2019 infection and diabetes in Daegu, South Korea","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.cjco.2021.04.004_bib0099","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","article-title":"Proinflammatory actions of angiotensins","volume":"10","author":"Ruiz-Ortega","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cjco.2021.04.004_bib0100","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0101","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.7150\/ijbs.7.1077","article-title":"Cardioprotective effects of telmisartan against heart failure in rats in-duced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2\/angiotensin 1-7\/Mas receptor axis","volume":"7","author":"Sukumaran","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.cjco.2021.04.004_bib0102","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1152\/ajpheart.00937.2006","article-title":"Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)","volume":"292","author":"Grobe","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0103","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.arcmed.2007.07.010","article-title":"ACE2 overexpression inhibits angiotensin ii-induced monocyte chemoattractant protein-1 expression in macrophages","volume":"39","author":"Guo","year":"2008","journal-title":"Arch Med Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0104","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.200811-1678OC","article-title":"Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension","volume":"179","author":"Ferreira","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.lfs.2011.11.018","article-title":"Telmisartan acts through the modulation of ACE-2\/ANG 1-7\/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis","volume":"90","author":"Sukumaran","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.cjco.2021.04.004_bib0106","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/cvr\/cvr242","article-title":"ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension","volume":"92","author":"Sriramula","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/db15-0399","article-title":"ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity","volume":"65","author":"Patel","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cjco.2021.04.004_bib0108","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.117.10280","article-title":"Favorable vascular actions of angiotensin-(1-7) in human obesity","volume":"71","author":"Schinzari","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.04.004_bib0109","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0110","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jmv.25785","article-title":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19","volume":"92","author":"Cheng","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0111","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0112","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17460441.2019.1581171","article-title":"Broad-spectrum coronavirus antiviral drug discovery","volume":"14","author":"Totura","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.cjco.2021.04.004_bib0113","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa040419","article-title":"Avian influenza A (H5N1) in 10 patients in Vietnam","volume":"350","author":"Tran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0114","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms?","volume":"8","author":"Spagnolo","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0116","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1165\/rcmb.2012-0451OC","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1-7)\/mas axis protects against lung fibrosis by inhibiting the MAPK\/NF-\u03baB pathway","volume":"50","author":"Meng","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0117","doi-asserted-by":"crossref","first-page":"L325","DOI":"10.1152\/ajplung.00189.2020","article-title":"Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2 related lung injury","volume":"319","author":"Sarzani","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40203-020-00058-7","article-title":"Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study","volume":"9","author":"Nejat","year":"2021","journal-title":"Silico Pharmacol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0119","first-page":"120","article-title":"Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: a new promising approach for treating ARDS in patients with coronavirus infection","volume":"34","author":"Soheili","year":"2020","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.cjco.2021.04.004_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109193","article-title":"Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-\u03b21 in alveolar epithelial cells","volume":"117","author":"Shao","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cjco.2021.04.004_bib0121","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1089\/ars.2017.7261","article-title":"Autophagy attenuates angiotensin II-Induced pulmonary fibrosis by inhibiting redox imbalance-mediated NOD-like receptor family pyrin domain containing 3 inflammasome activation","volume":"30","author":"Meng","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.cjco.2021.04.004_bib0122","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/ars.2013.5818","article-title":"The angiotensin-converting enzyme 2\/angiotensin (1-7)\/mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA\/Rho kinase pathway","volume":"22","author":"Meng","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.cjco.2021.04.004_bib0123","doi-asserted-by":"crossref","first-page":"L178","DOI":"10.1152\/ajplung.00009.2008","article-title":"Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis","volume":"295","author":"Li","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0124","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-020-0451-z","article-title":"COVID-19 revisiting inflammatory pathways of arthritis","volume":"16","author":"Schett","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109876","article-title":"A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application","volume":"144","author":"Contini","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.cjco.2021.04.004_bib0126","first-page":"1","article-title":"The amount of cytokine-release defines different shades of Sars-Cov2 infection","author":"Bindoli","year":"2020","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0127","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1210\/me.2013-1146","article-title":"VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system","volume":"27","author":"Kong","year":"2013","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0128","article-title":"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study","volume":"203","author":"Castillo","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.04.004_bib0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/a-1155-0501","article-title":"The ACE-2 in COVID-19: foe or friend?","volume":"52","author":"Dalan","year":"2020","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0131","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin-II mediates ACE2 internalization and degradation through an angiotensin-II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.04.004_bib0132","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10096-020-03897-6","article-title":"Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening","volume":"39","author":"Zhao","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cjco.2021.04.004_bib0133","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/HJH.0000000000002666","article-title":"Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension","volume":"39","author":"Mancusi","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjco.2021.04.004_bib0134","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/HYPERTENSIONAHA.120.15324","article-title":"Age and multimorbidity predict death among COVID-19 Patients: Results of the SARS-RAS study of the Italian Society of Hypertension","volume":"76","author":"Iaccarino","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.04.004_bib0135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.120.16314","article-title":"Antihypertensive drugs and COVID-19 risk","volume":"77","author":"Semenzato","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.04.004_bib0136","first-page":"1","article-title":"Cardiovascular comorbidities and pharmacological treatments of Covid-19 patients not requiring hospitalization","volume":"18","author":"Russo","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cjco.2021.04.004_bib0137","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jamda.2020.09.004","article-title":"COVID-19 in-hospital mortality and use of renin-angiotensin system blockers in geriatrics patients","volume":"21","author":"Genet","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.cjco.2021.04.004_bib0138","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520979151","article-title":"Impact of renin\u2013angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study","volume":"48","author":"Zhong","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0139","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017364","article-title":"Antecedent administration of angiotensin-converting enzyme inhibitors or angiotensin ii receptor antagonists and survival after hospitalization for COVID-19 syndrome","volume":"9","author":"Palazzuoli","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjco.2021.04.004_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106805","article-title":"RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies","volume":"135","author":"de Castelnuovo","year":"2020","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0141","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s40292-020-00409-7","article-title":"Impact of treatment with renin\u2013angiotensin system inhibitors on clinical outcomes in hypertensive patients hospitalized with COVID-19","volume":"27","author":"Negreira-Caama\u00f1o","year":"2020","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.cjco.2021.04.004_bib0142","first-page":"1","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of Covid-19","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0143","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jch.14101","article-title":"Hypertension, medications, and risk of severe COVID-19: a Massachusetts community-based observational study","volume":"23","author":"Bauer","year":"2021","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.cjco.2021.04.004_bib0144","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.cjco.2021.04.004_bib0145","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/ajh\/hpaa149","article-title":"Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19","volume":"33","author":"Soleimani","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cjco.2021.04.004_bib0146","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41440-020-00535-8","article-title":"Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study","volume":"43","author":"Matsuzawa","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0147","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.04.004_bib0148","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/jch.13948","article-title":"Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain","volume":"22","author":"Vila-Corcoles","year":"2020","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"10.1016\/j.cjco.2021.04.004_bib0149","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijcard.2020.09.062","article-title":"The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: a retrospective, observational study in Northern Italy","volume":"324","author":"Desai","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0150","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.cjco.2021.04.004_bib0151","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.04.004_bib0152","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for Coronavirus disease 2019 (COVID-19) infection in Wuhan, China","volume":"5","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjco.2021.04.004_bib0153","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2021.04.004_bib0154","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X21000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X21000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:05:39Z","timestamp":1762902339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X21000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":154,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2589790X21000998"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2021.04.004","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classical and Counter-Regulatory Renin\u2013Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2021.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}